Mangoceuticals (MGRX) Retained Earnings (2022 - 2026)

Mangoceuticals has disclosed Retained Earnings across 5 years of filings, most recently posting $57.6 million for Q2 2026.

• In Q2 2026, Retained Earnings rose 13.34% year-over-year to $57.6 million; the TTM figure through Jun 2026 stood at $57.6 million (up 13.34% YoY), while the FY2025 annual figure was $55.5 million, up 59.62% from the prior year.
• Retained Earnings came in at $57.6 million for Q2 2026 at Mangoceuticals, up from $57.2 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $57.6 million in Q2 2026 to a low of -$13.6 million in Q1 2024.
• Average Retained Earnings over 5 years is $29.7 million, with a median of $31.6 million recorded in 2024.
• Year-over-year, Retained Earnings slumped 261.96% in 2024 and soared 437.38% in 2025.
• Over 5 years, Retained Earnings stood at $2.6 million in 2022, then soared by 356.65% to $12.0 million in 2023, then surged by 189.81% to $34.8 million in 2024, then soared by 59.62% to $55.5 million in 2025, then grew by 3.68% to $57.6 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $57.6 million in Q2 2026, $57.2 million in Q1 2026, and $55.5 million in Q4 2025.